The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study
- PMID: 28833488
- PMCID: PMC6362976
- DOI: 10.1002/gps.4772
The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study
Abstract
The effect of treating comorbid depression to achieve optimal management of chronic obstructive pulmonary disease (COPD) has not yet empirically tested. We examined the association between antidepressant treatment and use of and adherence to COPD maintenance medications among patients with new-onset COPD and comorbid depression.
Methods: Using 2006-2012 Medicare data, this retrospective cohort study identified patients with newly diagnosed COPD and new-onset major depression. Two exposures-antidepressant use (versus non-use) and adherence measured by proportion of days covered (PDC) (PDC ≥0.8 versus <0.8)-were assessed quarterly. We used marginal structural models to estimate the effects of prior antidepressant use and adherence on subsequent COPD maintenance inhaler use and adherence outcomes, accounting for time-varying confounders.
Results: A total of 25 458 COPD-depression patients, 82% with antidepressant treatment, were followed for a median of 2.5 years. Nearly half (48%) used at least 1 COPD maintenance inhaler in any given quarter; among users, 3 in 5 (61%) had a PDC of <0.8. Compared to patients with no antidepressant treatment, those with antidepressant use were more likely to use (relative ratio [RR] = 1.15, 95% confidence interval [CI] = 1.12- 1.17) and adhere to (RR = 1.08, 95% = 1.03-1.14) their COPD maintenance inhalers. Patients who adhered to antidepressant treatment were more likely to use and adhere to COPD maintenance inhalers.
Conclusion: Regularly treated depression may increase use of and adherence to necessary maintenance medications for COPD. Antidepressant treatment may be a key determinant to improving medication-taking behaviors among COPD patients comorbid with depression.
Keywords: COPD; adherence; depression; multiple conditions.
Copyright © 2017 John Wiley & Sons, Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
All authors have no conflict of interest.
Figures
Similar articles
-
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.Int J Geriatr Psychiatry. 2014 Jan;29(1):49-57. doi: 10.1002/gps.3968. Epub 2013 Apr 19. Int J Geriatr Psychiatry. 2014. PMID: 23606418 Free PMC article.
-
Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.Am J Geriatr Pharmacother. 2012 Jun;10(3):201-10. doi: 10.1016/j.amjopharm.2012.04.002. Epub 2012 Apr 21. Am J Geriatr Pharmacother. 2012. PMID: 22521808
-
Adherence and healthcare utilization among older adults with COPD and depression.Respir Med. 2017 Aug;129:53-58. doi: 10.1016/j.rmed.2017.06.002. Epub 2017 Jun 3. Respir Med. 2017. PMID: 28732836 Free PMC article.
-
Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes.Drugs Aging. 2014 Jul;31(7):483-92. doi: 10.1007/s40266-014-0186-0. Drugs Aging. 2014. PMID: 24902934 Free PMC article. Review.
-
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression.J Affect Disord. 2022 Mar 1;300:219-225. doi: 10.1016/j.jad.2021.12.083. Epub 2021 Dec 22. J Affect Disord. 2022. PMID: 34952118 Review.
Cited by
-
Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression.J Manag Care Spec Pharm. 2023 Apr;29(4):431-445. doi: 10.18553/jmcp.2023.29.4.431. J Manag Care Spec Pharm. 2023. PMID: 36989452 Free PMC article.
-
Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.J Psychosom Res. 2019 Mar;118:18-26. doi: 10.1016/j.jpsychores.2019.01.002. Epub 2019 Jan 7. J Psychosom Res. 2019. PMID: 30782350 Free PMC article.
-
Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease.Lung India. 2019 May-Jun;36(3):193-198. doi: 10.4103/lungindia.lungindia_340_18. Lung India. 2019. PMID: 31031337 Free PMC article.
-
Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic.Ann Transl Med. 2020 Sep;8(18):1179. doi: 10.21037/atm-20-6016. Ann Transl Med. 2020. PMID: 33241028 Free PMC article.
-
Methods to assess COPD medications adherence in healthcare databases: a systematic review.Eur Respir Rev. 2023 Sep 27;32(169):230103. doi: 10.1183/16000617.0103-2023. Print 2023 Sep 30. Eur Respir Rev. 2023. PMID: 37758274 Free PMC article.
References
-
- Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for2013. Natl Vital Stat Rep. 2016;64(2):1–119. - PubMed
-
- Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011;63:1–8. - PubMed
-
- Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin. 2009;25(11):2729–2735. - PubMed
-
- Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009; 38(1):34–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical